Head and Neck Neoplasm
30
2
4
17
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
3 terminated out of 30 trials
85.0%
-1.5% vs benchmark
7%
2 trials in Phase 3/4
24%
4 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (30)
Oropharynx (OPX) Biomarker Trial
Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer
GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma
Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients with Head and Neck Cancer
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
HARE-40: HPV Anti-CD40 RNA vaccinE
Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors
Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma
A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.
Feasibility and Safety of Aerobic Exercise for Head and Neck Cancer Patients
Characteristics of a Maxillofacial Prosthesis Consultation Within Assistance Publique - Hopitaux de Paris
Endoscopic Direct-PEG Placement in Patients Unable to Undergo Pull-PEG Procedure
Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC)
SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N
Eletric Stimulation for Hipossalivation Induced by Radiotherapy